Locoregional application of 213Bi-[Thi8,Met(O2)11]-substance P for treatment of gliomas has been found safe after injection of doses of 2 GBq in 2-month interval up to cumulative doses of 11.2 GBq with only mild and transient adverse reactions. Here, TAC1 is linked to central nervous system cancer.